Archive for the ‘affymetrix’ Category

Affymetrix beefs up cancer research offerings in $330M eBioscience buyout

November 30th, 2011 Ryan McBride

Affymetrix ($AFFY) took a big step forward in its pursuit of a larger swath of the market for cancer and immunology research products, announcing Wednesday that it has struck a deal to scoop up eBioscience for $330 million in cash. The pact comes after…

Posted in affymetrix, Blog, Companies, Diagnostics, eBioscience, Funding, Medical Devices, Medical Supply, Pharmaceuticals, Startups, Universities, Videos Tags: Comments Off
Read More »